spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ActivBiotics 

 HSMN NewsFeed - 7 Sep 2010
Cubist Pharmaceuticals Announces Promotion of Steven C. Gilman, Ph.D., to EVP, Research and Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Dec 2009
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Feb 2008
Cubist Pharmaceuticals Names Steven C. Gilman, Ph.D., as Senior Vice President, Discovery and Non-Clinical Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Nov 2007
Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2007
Transave, Inc. Appoints Mich Soga as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 May 2007
ActivBiotics, Inc. Appoints Steven C. Gilman Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Panacos Appoints Alan W. Dunton, M.D. as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2006
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2006
ActivBiotics, Inc. Announces Completion of Patient Enrollment in Phase III Clinical Trial in Peripheral Arterial Disease
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2006
ActivBiotics Receives FDA Fast Track Status for Rifalazil in Peripheral Arterial Disease
Biopharmaceuticals
 HSMN NewsFeed - 11 Jan 2006
ActivBiotics and Metaphore Complete Merger Creating Late-Stage Company Addressing Serious Infections and Inflammation
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
ActivBiotics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.